Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
5 March 2015
Header
Header image
Highlight of the week

News

TTIP- Facts, figures, benefits
05 March 2015

EFPIA today has published two information brochures on the Transatlantic Trade and Investment Partnership that is currently being negotiated: A myth-buster, to reflect on the [...] Read more

From our blog

Transatlantic Trade and Investment Partnership (TTIP): Towards better health outcomes for patients and economic growth
05 March 2015 (Presentations)

Read more

Highlight of the week

TTIP: Understanding the Benefits, Dispelling the Myths
05 March 2015

The world’s largest trading partnership – between the EU and the U.S. – is set to get a significant boost should the Transatlantic Trade and Investment Partnership (TTIP) become a reality. It certainly represents a great chance to strengthen the transatlantic pharmaceutical market and deliver better health outcomes. An ambitious TTIP agreement would spur transatlantic trade and investment in life sciences and foster research cooperation, thereby increasing patient access to innovative medicines on both sides of the Atlantic. We see numerous benefits stemming from TTIP – benefits for patients, science and the economy.

Read more

News

News

Open letter from Richard Bergström, EFPIA Director General to the Competitiveness Council
03 March 2015

Richard Bergström, EFPIA Director General is inviting the Competitiveness Council in an open letter to establish a working group on big data in healthcare. Drawing on [...] Read more

News

EFPIA and APRaD Sign Letter of Intent to Advance Healthcare Reform in Ukraine
04 March 2015

Healthcare reform in Ukraine is set to take a significant step forward following the signing on March 3rd, of a Letter of Intent by the [...] Read more

From our blog

From our blog

Attacking the Patent System for Pricing Issues Is a Non-Starter
05 March 2015 by Richard Bergström

Gilead Sciences’ hepatitis C treatment, Sovaldi, has been a regular feature in healthcare news of late, not least because it offers that most elusive of gifts: a cure. There has been much discussion about its price, but also a recognition of the value that this drug offers to society. If a patient is successfully treated with Sovaldi, ongoing treatment costs are nullified, including significant expenditure on care, and that patient may return to work delivering further economic benefits to society.

Read more

Events calendar

Events Calendar

WEBINAR: Stem Cells, Gene Therapies, and Tissue Engineering: How do we Put Advanced Therapies into Practice in Europe?
On 16/03/2015

How will Advanced Therapies change treatment pathways and improve patient outcomes? This webinar will highlight the current cutting edge of medical sciences, and discuss how Europe is moving these new technologies into practice by breaking down regulatory hurdles that may block their adoption.

This webinar is in support of the new report on Advanced Therapies being released by EBE and Vital Transformation in Lyon, April 15th at the BioVision conference.

Read more

Events Calendar

Countdown - 1 week: EFPIA Annual Meetings 3-5 June 2015
From 03/06/2015 to 05/06/2015 (Luxembourg)

Only 1 week to go - Register Urgently

EFPIA will be holding its 2015 Annual Meetings from 3 to 5 June in Luxembourg. The event provides an unparalleled opportunity to discuss the key issues driving the European pharmaceutical and healthcare agenda as well as network with senior industry and European stakeholders.

PROGRAMME

REGISTRATION

 

Read more

Events Calendar

Pharmaceutical Compliance Congress and Best Practices Forum
From 11/05/2015 to 13/05/2015 (Brussels)

The Ninth International Pharmaceutical Compliance Congress and Best Practices Forum will address the leading pharmaceutical and medical device ethics and compliance issues in the European Union (EU) and include updates from Central and Eastern Europe (CEE), the Middle East and Africa (MEA) and India.

For the detailed event brochure, please follow the link below:

www.efpia.eu/uploads/International_Pharma_2015.pdf

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail